Prevalence of Charles Bonnet syndrome in patients with glaucoma: a systematic review with meta-analyses.
Charles Bonnet syndrome
glaucoma
visual hallucinations
Journal
Acta ophthalmologica
ISSN: 1755-3768
Titre abrégé: Acta Ophthalmol
Pays: England
ID NLM: 101468102
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
03
04
2020
revised:
21
05
2020
accepted:
02
07
2020
pubmed:
5
8
2020
medline:
23
9
2021
entrez:
5
8
2020
Statut:
ppublish
Résumé
Glaucoma is a widespread sight-threatening condition often only recognized when very pronounced. It is initially characterized by peripheral visual field losses, while advanced stages also affect the central vision. Some of these patients may experience visual hallucinations, the Charles Bonnet syndrome (CBS). In this systematic review and meta-analysis, we provide an overview of the literature dealing with the prevalence of CBS in patients with glaucoma. We searched the databases PubMed/MEDLINE, Embase, Web of Science, the Cochrane Central and PsycInfo on 22 March 2020. Eight studies (n = 827 patients) were identified and included for a qualitative and quantitative analysis. No studies included a representative sample of patients with only glaucoma. In patients with glaucoma in different stages and with ocular comorbidities, prevalence of CBS was 2.8% (CI95%: 0.7-6.1%). Among patients with glaucoma where all had bilateral low visual acuity, prevalence of CBS was 13.5% (CI95%: 8.4-19.6%). In patients with glaucoma who visited vision rehabilitation clinics, presumably due to an extensive vision impairment, prevalence of CBS was 20.1% (CI95%: 16.8-23.6%). Risk factors of CBS besides low vision were high age, female gender, reduced contrast sensitivity and not living alone. Taken together, we find that CBS may not be rare in patients with advanced glaucoma with and without ocular comorbidities. However, limitations of the current literature should be highlighted and careful approach towards conclusions is important. More studies are needed to better understand the prevalence and risk factors among different populations of patients with glaucoma.
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
128-133Informations de copyright
© 2020 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.
Références
Barendregt JJ, Doi SA, Lee YY & Norman RE, & Vos T (2013): Meta-analysis of prevalence. J Epidemiol Community Health 67(11): 974-978.
Bonnet C. (1769): Essai Analytique sur les Faculties de l’Ame. Copenhaven & Geneva: Tom.
Cantin S, Duquette J, Dutrisac F et al. (2019): Charles Bonnet syndrome: development and validation of a screening and multidimensional descriptive questionnaire. Can J Ophthalmol 54: 323-327.
Esteves Leandro J, Beato J, Pedrosa AC, Pinheiro-Costa J, Falcão M, Falcão-Reis F & Carneiro ÂM (2020): Clinical characteristics of the Charles Bonnet syndrome in patients with neovascular-age related macular degeneration: the importance of early detection. Ophthalmic Res [Epub ahead of print] https://doi.org/10.1159/000506137.
Gordon KD (2016): Prevalence of visual hallucinations in a national low vision client population. Can J Ophthalmol 51: 3-6.
Gordon KD & Felfeli T (2018): Family physician awareness of Charles Bonnet syndrome. Fam Pract 35: 595-598.
Higgins JPT & Green S. eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [Updated March 2011]. The Cochrane Collaboration, 2011. Available at: http://handbook-5-1.cochrane.org. Accessed April 17th, 2019.
Hou Y & Zhang Y (2012): The prevalence and clinical characteristics of Charles Bonnet syndrome in Chinese patients. Gen Hosp Psychiatry 34: 566-570.
Jackson ML, Drohan B, Agrawal K & Rhee DJ (2011): Charles Bonnet Syndrome and glaucoma. Ophthalmology 118: 1005.e2.
Moher D, Liberati A, Tetzlaff J & Altman DG & PRISMA Group (2009): Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339: b2535.
Nesher R, Nesher G, Epstein E & Assia E (2001): Charles Bonnet syndrome in glaucoma patients with low vision. J Glaucoma 10: 396-400.
Niazi S, Krogh Nielsen M, Singh A, Sørensen TL & Subhi Y (2020): Prevalence of Charles Bonnet syndrome in patients with age-related macular degeneration: systematic review and meta-analysis. Acta Ophthalmol 98: 121-131.
Roed Rasmussen ML, Prause JU, Johnson M & Toft PB (2009): Phantom eye syndrome: types of visual hallucinations and related phenomena. Ophthalmic Plast Reconstr Surg 25: 390-393.
Santos-Bueso E, Serrador-García M, Sáenz-Francés F, Méndez-Hernández C, Morales-Fernández L, Martínez-de-la-Casa JM, García-Feijoo J & Porta-Etessam J (2017): Charles Bonnet syndrome in a child with congenital glaucoma. Arch Soc Esp Oftalmol 92: 398-400.
Satgunam P, Sumalini R, Chittapu G & Pamarthi G (2019): Screening for Charles Bonnet syndrome: Should the definition be reconsidered? Indian J Ophthalmol 67: 1127-1132.
Singh A, Subhi Y & Sørensen TL (2014): Low awareness of the Charles Bonnet syndrome in patients attending a retinal clinic. Dan Med J 61: A4770.
Smith CS, Nichols J & Riaz KM (2018): Remission of Charles Bonnet syndrome after cataract extraction. Can J Ophthalmol 53: e221-e222.
Stroup DF, Berlin JA, Morton SC et al. (2000): Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008-2012.
Tan CS, Lim VS, Ho DY, Yeo E, Ng BY & Au Eong KG (2004): Charles Bonnet syndrome in Asian patients in a tertiary ophthalmic centre. Br J Ophthalmol 88: 1325-1329.
Teunisse RJ, Cruysberg JR, Verbeek A & Zitman FG (1995): The Charles Bonnet syndrome: a large prospective study in The Netherlands. A study of the prevalence of the Charles Bonnet syndrome and associated factors in 500 patients attending the University Department of Ophthalmology at Nijmegen. Br J Psychiatry 166: 254-257.
Tham YC, Li X, Wong TY, Quigley HA, Aung T & Cheng CY (2014): Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 121: 2081-2090.
Vacchiano V, Tonon C, Mitolo M et al. (2019): Functional MRI study in a case of Charles Bonnet syndrome related to LHON. BMC Neurol 19: 350.
Vahdani K, Poon JS, Antoniou E, Giasin O & Makrygiannis G (2017): Charles Bonnet Syndrome following eyelid reconstruction surgery. Ophthalmic Plast Reconstr Surg 33: 229-230.
Wall J, Bianchi M & Sunness JS (2017): Characteristics of a low vision glaucoma population. Invest Ophthalmol Vis Sci 58: 4661.
Weinreb RN, Aung T & Medeiros FA (2014): The pathophysiology and treatment of glaucoma: a review. JAMA 311: 1901-1911.
Zeng X, Zhang Y, Kwong JS, Zhang C, Li S, Sun F, Niu Y & Du L (2015): The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med 8: 2-10.